Testing platelet treatment in ICU patients after surgery
Part of Blood & lymphatic clinical trials.
This trial studies whether a platelet-related treatment can work better in people in the ICU who need a platelet transfusion after surgery. It may help reduce bleeding by improving how platelets work when certain blood clotting proteins are already high.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You are currently an ICU patient
- You need a platelet transfusion during or after surgery
- You (or your family) can give consent, and an independent ICU doctor agrees
- You have not received Factor VIII concentrate (Haemate®) before joining the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving platelet transfusions to critically ill patients with very low platelet counts helps prevent dangerous bleeding. If you're in the ICU with a very low platelet count, this trial might help decide the best way to keep you safe.
This trial tests whether giving a platelet transfusion to patients with severe traumatic brain injury who are on antiplatelet medication can improve how well their blood clots. You may qualify if you have a serious brain bleed and are taking a medication like aspirin or clopidogrel.
This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
This trial tests two medications (lusutrombopag and recombinant human thrombopoietin) given together to raise platelet levels before a planned surgery in people with chronic liver disease. The goal is to reduce the need for platelet transfusions and make the procedure safer.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.